Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
108M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
+723K
-
Total reported value, excl. options
-
$283M
-
Value change
-
+$12.2M
-
Number of buys
-
38
-
Number of sells
-
-7
-
Price
-
$18.47
Significant Holders of Aclaris Therapeutics, Inc. - Common Stock (ACRS) as of Q2 2016
49 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock as of Q2 2016.
Aclaris Therapeutics, Inc. - Common Stock (ACRS) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 108M outstanding shares and own 14.17% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (4.19M shares), FMR LLC (2.79M shares), RA CAPITAL MANAGEMENT, LLC (2.63M shares), FRANKLIN RESOURCES INC (1.57M shares), Rock Springs Capital Management LP (1M shares), Cormorant Asset Management, LLC (901K shares), FIL Ltd (747K shares), VANGUARD GROUP INC (419K shares), BlackRock Fund Advisors (235K shares), and STATE STREET CORP (120K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.